Future Market Insights examines the global western blotting market for a five-year forecast period 2016-2021. FMI indicates that the market will see steady growth over the aforementioned period. The revenues are expected to reach US$ 551.0 Mn by the end of 2016 and the market may expand at a CAGR of 5.4% during 2016-2021.
The global western blotting market is segmented on the basis of type, end-use, and region.
By product, the global market for western blotting is segmented into electrophoresis blotting systems, reagents kits, and transfer membranes. The reagents kits segment is expected to retain dominance over the forecast period; however FMI indicates a declining growth rate for this segment post-2016. This segment will account for nearly US$ 426.4 Mn by 2021 end, capturing over 58% share of the market. It is further segmented into chromogenic, chemiluminescent, antibodies, fluorescent, and buffer. The electrophoresis blotting systems segment is likely to exhibit substantial growth at a CAGR of 7.4%, reaching a value of around US$ 222.9 Mn by 2021 end.
Based on end-use, the market is segmented into diagnostic laboratories, research institutions, and pharmaceutical and biotech companies. Among these, pharmaceutical and biotech companies segment will continue to lead with the maximum revenue share by 2021 end. However, research institutions segment is expected to thrive at a higher CAGR during the forecast period, followed by diagnostic laboratories segment with the least market share.
By geographical analysis, the global western blotting market is segmented into five key regional markets. North America is projected to continue dominance in 2016 through to 2021, primarily attributed to rising incidences of AIDS and Lyme disease, increased GMO crops production, and promising clinical research efforts. This region is also witnessing soaring research funds, in addition to an initiative for HIV vaccine development. While these factors are likely to drive the western blotting market in North America, the revenues of this region may reach US$ 253.8 Mn by 2021 end, accounting for over 35% share of the entire market value in 2021.
Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1050
Summary of Table of Content:
1. Research Methodology
2. Assumptions & Acronyms Used
3. Executive Summary
4. Global Western Blotting Market Overview
5. Global Western Blotting Market Analysis and Forecast By Product
6. Global Western Blotting Market Analysis and Forecast By Application
7. Global Western Blotting Market Analysis and Forecast By End Use
8. Global Western Blotting Market Analysis and Forecast By Region
9. Global Western Blotting Market: Competitive Landscape
10. Strategic Recommendations
Request to Browse Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/western-blotting-market/toc
The global western blotting market is segmented on the basis of type, end-use, and region.
By product, the global market for western blotting is segmented into electrophoresis blotting systems, reagents kits, and transfer membranes. The reagents kits segment is expected to retain dominance over the forecast period; however FMI indicates a declining growth rate for this segment post-2016. This segment will account for nearly US$ 426.4 Mn by 2021 end, capturing over 58% share of the market. It is further segmented into chromogenic, chemiluminescent, antibodies, fluorescent, and buffer. The electrophoresis blotting systems segment is likely to exhibit substantial growth at a CAGR of 7.4%, reaching a value of around US$ 222.9 Mn by 2021 end.
Based on end-use, the market is segmented into diagnostic laboratories, research institutions, and pharmaceutical and biotech companies. Among these, pharmaceutical and biotech companies segment will continue to lead with the maximum revenue share by 2021 end. However, research institutions segment is expected to thrive at a higher CAGR during the forecast period, followed by diagnostic laboratories segment with the least market share.
By geographical analysis, the global western blotting market is segmented into five key regional markets. North America is projected to continue dominance in 2016 through to 2021, primarily attributed to rising incidences of AIDS and Lyme disease, increased GMO crops production, and promising clinical research efforts. This region is also witnessing soaring research funds, in addition to an initiative for HIV vaccine development. While these factors are likely to drive the western blotting market in North America, the revenues of this region may reach US$ 253.8 Mn by 2021 end, accounting for over 35% share of the entire market value in 2021.
Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1050
Summary of Table of Content:
1. Research Methodology
2. Assumptions & Acronyms Used
3. Executive Summary
4. Global Western Blotting Market Overview
5. Global Western Blotting Market Analysis and Forecast By Product
6. Global Western Blotting Market Analysis and Forecast By Application
7. Global Western Blotting Market Analysis and Forecast By End Use
8. Global Western Blotting Market Analysis and Forecast By Region
9. Global Western Blotting Market: Competitive Landscape
10. Strategic Recommendations
Request to Browse Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/western-blotting-market/toc
No comments:
Post a Comment